DAMBKOWSKI CARL (Chief Medical Officer) sold 2.6% of their position (5.50K shares) of APOGEE THERAPEUTICS, INC. on the open market
Open‑market sale worth $462.8K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 5/9/2026ACC: 0001104659-26-058129
Officer· Chief Medical Officer
Since Mar 2026
-5.50K
Net shares
Net seller
$462.8K
Total sold
2
Open market trades
0B · 2S
4
Total transactions
4.13K acquired · 9.63K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+4.13K
Price / share
$22.86
Trade value
$94.30K
% of position
2.0%
5/6/2026
208.40K→212.52K
Common Stock
Direct
Shares
−3.70K
Price / share
$83.92
Trade value
$310.50K
% of position
1.7%
5/6/2026
212.52K→208.82K
Common Stock
Direct
Shares
−1.80K
Price / share
$84.60
Trade value
$152.28K
% of position
0.9%
5/6/2026
208.82K→207.02K
Total
Net shares
−1.38K
Net value
-$368.49K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/6/2026 | M · Option Exercise | +4.13K | $22.86 | $94.30K | 2.0% | 208.40K | 212.52K |
| Common Stock Direct | 5/6/2026 | S · Sale | −3.70K | $83.92 | $310.50K | 1.7% | 212.52K | 208.82K |
| Common Stock Direct | 5/6/2026 | S · Sale | −1.80K | $84.60 | $152.28K | 0.9% | 208.82K | 207.02K |
| Total | −1.38K | -$368.49K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
4.13K shares
Shares
−4.13K
Strike price
22.86
Held after
123.04K
Exercisable
—
5/6/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock4.13K shares | 5/6/2026 | M · Option Exercise | −4.13K | 22.86 | — | 123.04K |